LifeTech ScientificLFTSF 96 PB Ratio is 2.07 as of Jun. 30, 2026, which is 56% below its 10-year median of 4.70. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.36. The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 61.7% on this metric.
LifeTech Scientific Corp stock PB Ratio (=1.56) is close to 10-year low of 1.51.
The historical rank and industry rank for LifeTech Scientific's PB Ratio or its related term are showing as below:
LFTSF'
s PB Ratio Range Over the Past 10 Years
Min: 1.51 Med: 4.7 Max: 36.67
Current: 1.56
During the past 13 years, LifeTech Scientific's highest PB Ratio was 36.67. The lowest was 1.51. And the median was 4.70.
LFTSF's PB Ratio is ranked better than 61.7% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.085
vs LFTSF: 1.56
During the past 12 months, LifeTech Scientific's average Book Value Per Share Growth Rate was 4.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 25.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of LifeTech Scientific was 83.00% per year. The lowest was -16.60% per year. And the median was 19.30% per year.
Back to Basics: PB Ratio
LifeTech Scientific (OTCPK:LFTSF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
LifeTech Scientific PB Ratio Related Terms
LifeTech Scientific PB Ratio Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's PB Ratio distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
LifeTech Scientific (LFTSF) has a PB Ratio of 2.07 as of Jun. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on LifeTech Scientific and its competitors. This is 56% below median its historical median of 4.70. Over the past decade, LifeTech Scientific's PB Ratio has ranged from 1.51 to 36.67. According to the industry distribution chart, LifeTech Scientific ranks #301 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 38.3%.
Is LifeTech Scientific's PB Ratio too high?
LifeTech Scientific's current PB Ratio of 2.07 is 56% below median its 10-year median of 4.70. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 36.67. The Medical Devices & Instruments industry median PB Ratio is 2.09. LifeTech Scientific's value of 2.07 is 0.7% below this industry median. Based on the distribution chart, LifeTech Scientific ranks #301 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #301 out of 786 companies for PB Ratio. This puts LifeTech Scientific in the upper half of its industry. The industry median PB Ratio is 2.09. LifeTech Scientific's value of 2.07 is 0.7% below this benchmark. Historically, LifeTech Scientific's own PB Ratio has ranged from 1.51 to 36.67 over the past decade. While the company's 10-year median is 4.70 vs. the industry median of 2.09, LifeTech Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.09, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current PB Ratio of 2.07 is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current PB Ratio is 2.07, which is 56% below median its own 10-year median of 4.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current PB Ratio of 2.07. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current PB Ratio is 2.07, which is 56% below median its 10-year median of 4.70 and 0.7% below the Medical Devices & Instruments industry median of 2.09. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current PB Ratio is 2.07 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
PB Ratio: 2.07 (56% below median its 10-year median of 4.70)
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
Industry Position: 0.7% below the Medical Devices & Instruments median (#301 of 786)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
